Progressive vitreous deposits during treatment with inotersen for hereditary ATTR amyloidosis

The Swedish landscape of hereditary ATTR amyloidosis

Amyloid ◽

10.1080/13506129.2017.1286580 ◽

2017 ◽

Vol 24 (sup1) ◽

pp. 93-94 ◽

Author(s):

Ole B. Suhr ◽

Jonas Wixner ◽

Björn Pilebro ◽

Hans-Erik Lundgren ◽

Intissar Anan

Keyword(s):

Attr Amyloidosis ◽

Coexistence of wild type and hereditary ATTR amyloidosis in one family

Amyloid ◽

10.1080/13506129.2019.1690444 ◽

2019 ◽

Vol 27 (1) ◽

pp. 71-72

Author(s):

Josine G. Feenstra ◽

Hans L. A. Nienhuis ◽

Johan Bijzet ◽

Paul A. van der Zwaag ◽

Maarten P. van den Berg ◽

...

Keyword(s):

Wild Type ◽

Attr Amyloidosis ◽

TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patients

Amyloid ◽

10.1080/13506129.2020.1784134 ◽

2020 ◽

Vol 27 (4) ◽

pp. 250-253 ◽

Author(s):

Orly Moshe-Lilie ◽

Diana Dimitrova ◽

Stephen B. Heitner ◽

Thomas H. Brannagan ◽

Sasha Zivkovic ◽

...

Keyword(s):

Liver Transplant ◽

Gene Silencing ◽

Attr Amyloidosis ◽

Screening for Fabry disease and Hereditary ATTR amyloidosis in idiopathic small‐fiber and mixed neuropathy

Muscle & Nerve ◽

10.1002/mus.26348 ◽

2018 ◽

Vol 59 (3) ◽

pp. 354-357 ◽

Cited By ~ 2

Author(s):

Kristin Samuelsson ◽

Ana Radovic ◽

Rayomand Press ◽

Mari Auranen ◽

Emil Ylikallio ◽

...

Keyword(s):

Fabry Disease ◽

Attr Amyloidosis ◽

Small Fiber ◽

The landscape of treatment of chronic kidney disease in hereditary ATTR amyloidosis

Orphanet Journal of Rare Diseases ◽

10.1186/1750-1172-10-s1-i12 ◽

2015 ◽

Vol 10 (S1) ◽

Author(s):

Luisa Lobato

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Attr Amyloidosis ◽

Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy

BMC Neurology ◽

10.1186/s12883-017-0948-5 ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 95

Author(s):

David Adams ◽

Ole B. Suhr ◽

Peter J. Dyck ◽

William J. Litchy ◽

Raina G. Leahy ◽

...

Keyword(s):

Trial Design ◽

Controlled Study ◽

Phase 3 ◽

Attr Amyloidosis ◽

Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S)

Internal Medicine ◽

10.2169/internalmedicine.2456-18 ◽

2019 ◽

Vol 58 (18) ◽

pp. 2695-2698

Author(s):

Taku Nakase ◽

Taro Yamashita ◽

Yoshimasa Matsuo ◽

Toshiya Nomura ◽

Keiko Sasada ◽

...

Keyword(s):

The Novel ◽

Attr Amyloidosis ◽

Novel Variant ◽

A case of cerebral amyloid angiopathy-type hereditary ATTR amyloidosis with Y69H (p.Y89H) variant displaying transient focal neurological episodes as the main symptom

Amyloid ◽

10.1080/13506129.2019.1632829 ◽

2019 ◽

Vol 26 (4) ◽

pp. 251-252

Author(s):

Yumi Yamada ◽

Takao Fukushima ◽

Satoshi Kodama ◽

Hiroshi Shimizu ◽

Akiyoshi Kakita ◽

...

Keyword(s):

Cerebral Amyloid Angiopathy ◽

Amyloid Angiopathy ◽

Main Symptom ◽

Attr Amyloidosis ◽

Cerebral Amyloid ◽

Electrophysiological demyelinating features in hereditary ATTR amyloidosis

Amyloid ◽

10.1080/13506129.2018.1564903 ◽

2019 ◽

Vol 26 (1) ◽

pp. 15-23 ◽

Author(s):

Nobuhiko Ohashi ◽

Minori Kodaira ◽

Hiroshi Morita ◽

Yoshiki Sekijima

Keyword(s):

Attr Amyloidosis ◽

Changes in Nerve Conduction Studies predates clinical symptoms onset in early onset Val30Met hereditary ATTR amyloidosis

European Journal of Neurology ◽

10.1111/ene.15176 ◽

2021 ◽

Author(s):

José Castro ◽

Bruno Miranda ◽

Isabel de Castro ◽

Isabel Conceição

Keyword(s):

Nerve Conduction ◽

Early Onset ◽

Clinical Symptoms ◽

Nerve Conduction Studies ◽

Attr Amyloidosis ◽